Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Omda Cytodose, an oncology medication management solution from Omda, employs clinically validated protocols along with patient-specific parameters to ensure safer and more effective treatments for individuals battling cancer. This innovative system enhances the quality of care provided to oncology patients by fostering a seamless and collaborative treatment process among healthcare professionals, including doctors, pharmacists, and nurses. Omda Cytodose is designed to support a comprehensive range of adult and pediatric cancers, accommodating various medical treatments such as chemotherapy, immunotherapy, hormone therapy, and additional supportive medications. Initially created by a team of clinicians at one of Norway's premier cancer centers and introduced in 2001, Omda Cytodose has gained widespread adoption across healthcare regions in the Nordic countries, leading to the fulfillment of millions of medication orders. With a robust 15-year history marked by stability, reliability, and safety, the system is meticulously configured with chemotherapy protocols that reflect both national and international guidelines. This ensures that patients receive the most up-to-date treatment options available, further enhancing their chances of successful outcomes.
Description
The product evaluates a patient's risk level to create a tailored digital screening plan, ensuring more reliable follow-up recommendations and enhancing diagnostic accuracy. This strategy is particularly effective in identifying cancers in women who are at heightened risk. WRRisk integrates a fully digital breast cancer risk assessment that utilizes patient-completed digital forms alongside a density evaluation to generate a comprehensive risk scorecard. By automating numerous manual processes, such as form collection and letter creation, WRRisk streamlines the management of breast risk programs, eliminating the need for paper documentation. This innovative product empowers both patients and healthcare providers with essential information, enhancing the overall care experience. Additionally, WRRisk provides calculations for ten-year and lifetime risk, as well as assessments based on secondary density metrics.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Omda
Founded
1999
Country
Norway
Website
omda.com/solutions/medication-management/omda-cytodose/
Vendor Details
Company Name
Whiterabbit.ai
Founded
2017
Country
United States
Website
www.whiterabbit.ai/products/wrrisk